Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2003
10/22/2003EP1353622A2 Method of improving systemic exposure of subcutaneously administered therapeutic proteins
10/22/2003EP1353569A2 Preparation for improved dietary utilisation
10/22/2003EP1281715B1 Process for the preparation of ribavirin
10/22/2003EP1204676B1 Streptogramin derivatives, preparation and compositions containing same
10/22/2003EP1196135B1 Compositions comprising organosiloxane resins for delivering oral care substances
10/22/2003EP1104446B1 Biologically active fraction of vegetable melanin, process for its production and its use
10/22/2003EP0948319B1 Encapsulated cells producing antibodies
10/22/2003EP0928136B1 Injectable compositions
10/22/2003EP0922059B1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
10/22/2003EP0863901B1 Carbapenem antibiotic, composition and method of preparation
10/22/2003EP0851927B1 Compounds for immunotherapy and diagnosis of tuberculosis
10/22/2003EP0651654B1 Use of lysozyme dimer for the manufacture of a medicament for modulating natural defensive mechanisms
10/22/2003CN1451046A 保守的奈瑟球菌抗原 Conservative Neisseria antigen
10/22/2003CN1451045A IFN-alpha homologues
10/22/2003CN1451038A Attenuated influenza virus useful as vaccine
10/22/2003CN1451014A Peptidomimetic protease inhibitors
10/22/2003CN1451011A 7-acylamino-3-heteroarylthio-3-cephem carboxylic and prodrugs thereof
10/22/2003CN1451005A 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
10/22/2003CN1451004A 7-oxo pyridopyrimidines
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450996A 2-guanidino-4-aryl-quinazoline
10/22/2003CN1450992A Piperazine derivatives used as CCR5 antagonists
10/22/2003CN1450990A Inhibitors of neuraminidases
10/22/2003CN1450989A 7-substituted tetracycline compounds
10/22/2003CN1450909A Monoclonal antibodies and antibody cocktail for detection of prion protein as an indiction of transmissible spongiform encephalopathies
10/22/2003CN1450903A Processes for preparing clarithromycin polymorphs
10/22/2003CN1450893A Method for treatment of sepsis
10/22/2003CN1450239A Emergency door opening system
10/22/2003CN1450164A Novel coronal virus strain and medicinal use thereof
10/22/2003CN1450084A Novel process for preparing recombinaant CHO cell hepatitis B vaccine
10/22/2003CN1450066A Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant
10/22/2003CN1450062A Coumarin group compound, synthesis process and use thereof
10/22/2003CN1449833A Human SARS immune globulin
10/22/2003CN1449832A Horse SARS-resisting serum
10/22/2003CN1449831A DNA vaccine pVPS2 for SARS virus
10/22/2003CN1449830A DNA vaccine pVFS for SARS virus
10/22/2003CN1449829A DNA vaccine pVPS for SARS virus
10/22/2003CN1449828A DNA vaccine pVPM for SARS virus
10/22/2003CN1449827A DNA vaccine pVPH for SARS virus
10/22/2003CN1449826A Gene vaccine for anti SARS coronal virus and use thereof
10/22/2003CN1449825A Method for inactivating Bordetella bronchiseptica culture, bacteria composition prepared by same and vaccine having same and use thereof
10/22/2003CN1449824A Process for preparing bacterial vaccine for aquiculture animal
10/22/2003CN1449823A Use of ulinastatin in treating SARS and medicinal composition thereof
10/22/2003CN1449822A New use of gene recombinant human lysozyme in pharmacy for curing coronal virus of SARS
10/22/2003CN1449821A Stable recombination human alpha interferon liquid preparation and productive process thereof
10/22/2003CN1449820A Interferon lozenge ice block and making method and use thereof
10/22/2003CN1449818A Decoction for anti-SARS
10/22/2003CN1449817A Traditional Chinese medicine capable of anti-SARS and treating cardio-cerebral vascular embolism
10/22/2003CN1449815A Medicine for treating inflammation
10/22/2003CN1449814A Traditional Chinese medicine composition for treating SARS and preparation process thereof
10/22/2003CN1449813A Medicine for treating SARS
10/22/2003CN1449809A Medicine for treating hepatitis B
10/22/2003CN1449808A Chinese herb lotion for treating onychomycosis and preparation process thereof
10/22/2003CN1449805A Traditional Chinese medicine for dispelling wind and removing heat and preparation process thereof
10/22/2003CN1449800A Traditional Chinese medicine for treating wind-cold type of common cold and preparation process thereof
10/22/2003CN1449794A Radix bupleuri soft capsule pharmaceutics and preparation process thereof
10/22/2003CN1449789A Novel antibiotic preparation and process for preparing the same
10/22/2003CN1449782A Compound cactsu antivirus preparation
10/22/2003CN1449766A Yinhuang (honeysuckle and Rdix astragali) soft capsule pharmaceutics and preparation process thereof
10/22/2003CN1449764A Roxithromycin slow-released pharmaceutics and preparation process thereof
10/22/2003CN1449753A Chlorogenic acid and isochlorogenic acid composition and medical use thereof
10/22/2003CN1449751A Use of dicaffeoylquinic acid derivative and analogs in treating disease related to coronavirus infection
10/22/2003CN1449749A Medicine for treating beriberi and preparation process thereof
10/22/2003CN1449744A Antifungal agent and preparation and use method
10/22/2003CN1449743A Medicinal aerosol and preparation process thereof
10/22/2003CN1125174C Recombinant phages
10/22/2003CN1125082C Human chemokine beta-8 chemokine beta-1 and macrophage inflammatory protein-4
10/22/2003CN1125079C Cyclopeptolides
10/22/2003CN1125076C New process for preparation of azithromycin
10/22/2003CN1125073C Process for preparing (-) pyridobenzoxazine carboxylic acid derviatives
10/22/2003CN1125068C Process for prodn. of purine derivatives
10/22/2003CN1125067C Crystalline antifungal polymorph
10/22/2003CN1125066C Tetrahydrofuran phosphate-and hydroxy esters as prodrugs for corresponding antifungal agent
10/22/2003CN1124855C Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and verterinary medical field
10/22/2003CN1124849C Nail health disinfecting liquid
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635749 Auxotrophic attenuated strain of Listeria with a mutation in genes whose protein product is essential for growth used to elicit a t-cell immune response to an antigen
10/21/2003US6635744 Substantially pure fibroblast growth factor homologous factor-4 polypeptide having specified amino acid sequence; diagnosis and treatment of neurodegenerative and neoplastic disorders
10/21/2003US6635680 Controlled release pellet formulation
10/21/2003US6635676 Non-toxic antimicrobial compositions and methods of use
10/21/2003US6635671 Compounds which affect mRNA stability and uses therefor
10/21/2003US6635644 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli
10/21/2003US6635642 Poly(ADP-ribose) polymerase inhibitors; tissue damage treatment
10/21/2003US6635629 For therapy and prophylaxis of inflammation, asthma, an allergic disease, chronic obstructive pulmonary disease, atopic dermatitis, solid tumors, AIDS, ischemia, and cardiac arrhythmias
10/21/2003US6635621 Alpha amino acid amide derivatives; reducing cathepsins B, L, S and/or K activity
10/21/2003US6635618 Glycopeptide phosphonate derivatives
10/21/2003US6635477 Comprising a open reading frame; use in diagnosis, treatment and prevention
10/21/2003US6635473 Isolated nucleic acid encoding a fibrinogen-binding protein; useful in prevention, diagnosis and treatment of infections; can be administered to wounds or for coating prosthetics to inhibit binding of the bacteria
10/21/2003US6635462 Mutated form of arginine deiminase
10/21/2003US6635461 Encoded by isolated nucleic acid; has glycosyltransferase activity; given amino acid sequence; useful as diagnostic and therapeutic agent for cancer and thymus-related disorders
10/21/2003US6635447 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms
10/21/2003US6635258 Herpes simplex virus VP22 vaccines and methods of use
10/21/2003US6635257 Oligomeric particle having diameter of 1 to 100 nanometer and consisting of hepatitis C virus envelope proteins, or parts thereof, in which at least one cysteine is alkylated
10/21/2003US6635248 Isolated polypeptide consisting of single chain of amino acids comprising one or more penetrating fragments from one or more penetrating antibodies, which penetrates into cell
10/21/2003US6635246 Nasally or orally administering composition comprising influenza virus antigen obtained from mammalian cell culture comprising protein-free media, and aluminum salt, being free of media and egg proteins, to provoke immune response
10/21/2003US6635242 Nursing bottle comprising container for breast milk, cap portion and nipple, and microbiocidal composition comprising sodium dodecyl sulfate, lithium dodecyl sulfate or lauric acid and salts in amount viricidal against non-enveloped virus
10/21/2003CA2288003C Pharmaceutical compositions of tizoxanide and nitazoxanide
10/21/2003CA2130926C Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof
10/21/2003CA2098020C Anti-viral compounds
10/21/2003CA2076432C Humanized antibody derivatives that recognize difucosyl lewis blood group antigens y-6 and b-7-2
1 ... 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 ... 1798